By utilising and developing innovative technologies, such as genomic sequencing, personalised screening and state-of-the-art diagnostics, to reduce levels of acute illness and support good health, Rutherford Diagnostics will revolutionise healthcare.
Rutherford Diagnostics will invest and facilite, at scale, the progression of genomics (the recording of whole genome sequence data).
Genomics will play an important part in ensuring a future where personalised medicine through genetic testing will predict disease, susceptibility and drug response.
Access to diagnostic services is central to disease management. Without diagnosis there can be no treatment, and there can be no cure. Its role is paramount in initiatives which aim to improve public health.
The fast access to state-of-the-art diagnostic technology that Rutherford Diagnostics will provide, could save lives and help people live well for longer.